Pilot corpus: NIH-funded biomedical datasets. Any DOI can be scored on demand — network effects sharpen as coverage grows.

Exploring treatment-driven subclonal evolution of prognostic triple biomarkers: Dual gene fusions and chimeric RNA variants in novel subtypes of acute myeloid leukemia patients with KMT2A rearrangement

Drug Resistance Updates(2025)10.1016/j.drup.2024.101199Source: DataRank Database

Exploring treatment-driven subclonal evolution of prognostic triple biomarkers: Dual gene fusions and chimeric RNA variants in novel subtypes of acute myeloid leukemia patients with KMT2A rearrangement is a research paper published in Drug Resistance Updates (2025). On theSindex it has a DataRank of 0. It has been cited 3 times.

N/A

0DataRank · unranked

Scored on demand from live citation data

Open Access3 citations

Download PDF

Cite:

DataRank reads this dataset's downstream impact straight off the citation graph — no black box, no proprietary weighting. How is this computed?

›Methodology & internals

datarank_citation_only_1hop_v6· scope data_onlyMethodology

Pipeline:MetadataData-paper checkEnrichmentCitation networkScoring

Enrichment:Funding (7 grants)Impact (FWCI 2.48)OA: hybridTopics (36)IDs (PubMed, PMC, OpenAlex)SDGs (1)

FAIR Checklist

Context only (not used in score)

Findable (1/2)

Has DOI

Accessible (1/2)

Open Access

Interoperable (0/2)

Reusable (0/3)

FAIR checklist signals are shown for context only and do not affect DataRank scoring.

Run a calibrated FAIR evaluation for this paper →

We only score data papers we can read in full — never from an abstract alone.

Authors (25)

Shengwen Calvin Li ORCID,Jeffrey Xiao ORCID,Qian Liu ORCID,Durga Cherukuri,Yan Liu ORCID

Live enrichment

PubMed:39823827 PMC:PMC12069159 OpenAlex:https://openalex.org/W4406018746

National Natural Science Foundation of China

Grant: 82020108004

Loma Linda University

Grant: 16004004

NIGMS NIH HHS

Grant: P20 GM121325

NCI NIH HHS

Grant: R01 CA197903

NCI NIH HHS

Grant: R01 CA251848

CHOC Children's Foundation

NIH

FWCI

2.48

Citation Percentile

0.9%

Citation Trend

2025

hybridLicense: cc-by

journalhttps://doi.org/10.1016/j.drup.2024.101199

publisherhttps://doi.org/10.1016/j.drup.2024.101199

publisherhttps://api.elsevier.com/content/article/PII:S1368764624001572?httpAccept=text/xml

publisherhttps://api.elsevier.com/content/article/PII:S1368764624001572?httpAccept=text/plain

repositoryhttps://pubmed.ncbi.nlm.nih.gov/39823827

Fields of Study

Acute Myeloid Leukemia ResearchMyeloproliferative Neoplasms: Diagnosis and TreatmentCancer Genomics and Diagnostics

MeSH Terms

AdultAgedFemaleHumansMaleMiddle AgedMyosinsPrognosisHistone-Lysine N-MethyltransferaseBiomarkers, TumorGene RearrangementLeukemia, Myeloid, AcuteOncogene Proteins, FusionKinesinsDrug Resistance, NeoplasmGene FusionMyeloid-Lymphoid Leukemia ProteinYoung Adult

Keywords

Myeloid leukemiaGeneFusion geneCancer researchMyeloidBiologyGeneticsAMlRelapseRefractoryChromosomal TranslocationKmt2aRna VariantsAfdnUnknown Gene Fusion

Sustainable Development Goals

SDG 0: Good health and well-being